Drug intelligence / Profile preview

benzoyl peroxide + tretinoin

Development stage
Approved
Lead developer
Sol-Gel Technologies
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

A fixed-dose topical combination of microencapsulated benzoyl peroxide (3%) and microencapsulated tretinoin (0.1%), developed for the treatment of acne vulgaris. Benzoyl peroxide acts as an anti-infective and oxidant with keratolytic properties, while tretinoin is a retinoid that functions as a retinoic acid receptor agonist to modulate epithelial cell growth and differentiation. The formulation uses Sol-Gel Technologies' proprietary microencapsulation technology to enhance stability and tolerability. The product is marketed under the brand name Twyneo for use in patients aged 9 years and older[1][2][3].

Brand names
TwyneoTWIN
Other names
microencapsulated benzoyl peroxide 3% and microencapsulated tretinoin 0.1% creamtretinoin/benzoyl-peroxide
02

Targets

RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on benzoyl peroxide + tretinoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benzoyl peroxide + tretinoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call